We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 6, 2018

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 27, 2018

    Lilly Migraine Med's Uncertain Future Kills Teva's Patent Suit

    A Massachusetts federal judge on Thursday cleared Eli Lilly and Co. from allegations that it infringed nine Teva Pharmaceuticals patents by preparing to launch a new migraine biologic, finding the suit is premature given that the U.S. Food and Drug Administration is still deciding whether to approve Lilly’s drug.


Parties

To view the parties, register now.